Skip to main content
Log in

Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model

  • Articles
  • Drug Development
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The effect of a main constituent ginsenoside Rg5 isolated from red ginseng and its metabolite ginsenoside Rh3 in a chronic dermatitis model was investigated. Ginsenosides Rg5 and Rh3 suppressed swelling of oxazolone-induced mouse ear contact dermatitis. These ginsenosides also reduced mRNA expressions of cyclooxygenase-2, interleukin (IL)-1β, tumor necrosis factor (TNF)-α and interferon (IFN)-γ. The inhibition of ginsenoside Rh3 was more potent than that of ginsenoside Rg5. These findings suggest that ginsenoside Rh3 metabolized from ginsenoside Rg5 may improve chronic dermatitis or psoriasis by the regulation of IL-1β and TNF-α produced by macrophage cells and of IFN-γ produced by Th cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akao, T., Kida, H., Kanaoka, M., Hattori, M., and Kobashi, K., Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.J. Pharm. Pharmacol., 50, 1155–1160 (1988).

    Google Scholar 

  • Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B., and Krueger, J. G., The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-r, interleukin-2, and tumor necrosis factor-α, defining Tc1 (cytotoxic T lymphocyte) and Th1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.J. Invest. Dermatol., 113, 752–759 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Bae, E. A., Han, M. J., Choo, M. K., Park, S. Y., and Kim, D.-H., Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation toin vitro biological activities.Biol. Pharm. Bull., 25, 58–63 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Bielory, L., Complementary and alternative interventions in asthma, allergy, and immunology.Ann. Allergy Asthma Immunol., 93(2 Suppl 1): S45–54 (2004).

    Article  Google Scholar 

  • Choo, M. K., Park, E. K., Han, M. J., and Kim, D.-H., Antiallergic activity of ginseng and its ginsenosides.Planta Med., 69, 518–522 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Fujii, Y., Takeuchi, H., Tanaka, K., Sakuma, S., Ohkubo, Y., and Mutoh, S., Effects of FK-506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats.Eur. J. Pharmacol., 456, 115–121 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Hernandez, G. L., Volpert, O. V., Iniguez, M. A., Lorenzo, E., Martinez-Martinez, S., Grau, R., Fresno, M., and Redondo, J. M., Selective inhibition of vascular endothelial growth factormediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.J. Exp. Med., 193, 607–620 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Keum, Y. S., Han, S. S., Chun, K. S., Park, K. K., Park, J. H., Lee, S. K., and Surh, Y. J., Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion.Mutat. Res., 523–524, 75–85 (2003).

    PubMed  Google Scholar 

  • Kim, D. S., Baek, N. I., Park, J. D., Lee, Y. H., Jeong, S. Y., Lee, C. B., Kim, S. I., Preparation and structure determination of a new glycoside, (20E)-ginsenoside Rh3, and its isomer from diol-type ginseng saponins.Yakhak Hoeji, 39, 85–93 (1995).

    CAS  Google Scholar 

  • Kitagawa, I., Yoshikawa, M., Yoshihara, M., Hayashi, T., and Taniyama, T., Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra.Yakugaku Zasshi, 103, 612–622 (1983).

    PubMed  CAS  Google Scholar 

  • Kown, S. W., Han, S. B., Park, I. H., Kim, J. M., Park, M. K., and Park, J. H., Liquid chromatographic determination of less polar ginsenosides in processed ginseng.J. Chromatogr. A., 921, 335–339 (2001).

    Article  Google Scholar 

  • Mochizuki, M., Yoo, Y. C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K., and Azuma, I., Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside Rg3 of Red ginseng.Biol. Pharm. Bull. 18, 1197–1202 (1995).

    PubMed  CAS  Google Scholar 

  • Nicoloff, B. J., The cytokine network in psoriasis.Arch. Dermatol., 127, 871–884 (1991).

    Article  Google Scholar 

  • Park, E. K., Choo, M. K., Han, M. J., and Kim, D. H., Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities.Int. Arch. Allergy Immunol., 133, 113–120 (2003).

    Article  CAS  Google Scholar 

  • Park, E. K., Choo, M. K., Kim, E. J., Han, M. J., and Kim, D. H., Antiallergic activity of ginsenoside Rh2.Biol. Pharm. Bull., 26, 1581–1584 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., and Amaya, T., Goto T. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).Int. Immunopharmacol., 1, 1219–1226 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Schafer-Korting, M., Schmid, M. H., and Korting, H. C., Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.Drug Safety, 14, 375–385 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C., and Kim, D. H., Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis.Int. Immunopharmacol., 5, 1183–91 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Simons, F. E., The antiallergic effects of antihistamines (H1-receptor antagonists).J. Allergy Clin. Immunol., 90, 705–715, (1992).

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, N., Tanaka, O., and Shibata, S., Chemical studies on the oriental plant drugs. XXVIII. Saponins and sapogenins of ginseng; Stereochemistry of sapogenin of ginsenoside Rb1, Rb2 and Rc.Chem. Pharm. Bull., 20, 1212–1216 (1972).

    Google Scholar 

  • Wakabayashi, C., Hasegawa, H., Murata, J., and Saiki, I., In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.Oncol. Res., 9, 411–417 (1998).

    Google Scholar 

  • Wu, J. Y., Gardner, B. H., Murrphy, C. I., Seals, J. R., Kensil, C. R., Recchia, J., Beltz, G. A., Newman, G. W., and Newman, M. J., Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.J. Immunol., 148, 1519–1525 (1992).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dong -Hyun Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, Y.W., Bae, E.A. & Kim, D.H. Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model. Arch Pharm Res 29, 685–690 (2006). https://doi.org/10.1007/BF02968253

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02968253

Key words

Navigation